Webinars and Upcoming Events for Dermatologists

EVENTS

Learn more about the upcoming events helping to transform atopic dermatitis (AD) for Dermatologists

EVENTS

Visit the DUPIXENT Expert Hub to watch past Sanoﬁ webinars and talking head videos from experts in the ﬁeld of dermatology.

Visit the Expert Hub

Resources

Find out what resources are available to help provide further information and support in treating your patients with AD.

Find out more

Overview of AD

Find out more about how AD has a continuous inflammation cycle.

Find out more

Reimbursement

Learn about the reimbursement of DUPIXENT in England, Wales and Scotland.

Find out more

AD, atopic dermatitis.

References

DUPIXENT Summary of Product Characteristics. September 2021.

MAT-IE-2101032(v4.0) | Date of preparation: February 2022

Sanofi and Regeneron are collaborating in a global development programme and commercialisation for Dupixent.

Great Britain Summary of Product Characteristics Northern and Republic of Ireland Summary of Product Characteristics

You are about to leave this website.

This link takes you to a third party website. Sanofi Genzyme has no control over the content of the website you are about to access. The terms of usage of the third party website will differ from that of the www.dupixent.co.uk. It is recommended that you carefully read the legal notice, cookies and privacy policy of third party websites before accessing these sites.

By continuing you are acknowledging that you have read this notice.

MAT-IE-2101043(v3.0) | Date of preparation: October 2021

CONTINUE